文献速递组学、生物样本库与精准医学流行病学与生物统计基础与转化研究

晚期黑色素瘤中肠道微生物组与免疫检查点抑制剂应答的跨队列关联

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.
PubMed 文献 · Nat Med · 2022-02-28

研究对五个观察性队列中165例晚期皮肤黑色素瘤患者ICI治疗前粪便行鸟枪法宏基因组测序,并整合147份已发表宏基因组样本。发现肠道微生物组与ICI应答存在相关但依赖队列,机器学习证实其与总缓解率和无进展生存期相关,但微生物组特征跨队列可重复性有限。

要点

  • 肠道微生物组与ICI应答的关联存在但依赖队列。
  • 机器学习证实微生物组与ORR和PFS相关,但特征跨队列可重复性有限。
  • 与应答者相关的物种包括假小链双歧杆菌、罗斯氏菌属和嗜黏蛋白阿克曼菌,但无单一物种可作为完全一致的生物标志物。

核心结论

  • 肠道微生物组与ICI应答的关联比先前认为的更复杂,超出应答者与非应答者之间简单存在或缺失的微生物物种差异。
  • 未来研究应采用更大样本量并考虑临床因素与肠道微生物组在治疗过程中的复杂相互作用。

研究设计与样本

  • 对五个观察性队列中招募的ICI初治晚期皮肤黑色素瘤患者(n=165)在ICI开始前采集的粪便样本行鸟枪法宏基因组测序。
  • 将数据集与先前发表研究的147份宏基因组样本整合。

主要发现

  • 肠道微生物组与ICI应答存在相关但依赖队列的关联。
  • 机器学习分析证实微生物组与ICI的总缓解率(ORR)和无进展生存期(PFS)相关,但也显示基于微生物组的特征跨队列可重复性有限。
  • 识别出与应答者相关的物种组合,包括假小链双歧杆菌、罗斯氏菌属和嗜黏蛋白阿克曼菌,但无单一物种可被视为跨研究完全一致的生物标志物。

局限性

  • 微生物组特征跨队列可重复性有限。
  • 无单一物种可被视为跨研究完全一致的生物标志物。
  • 未来研究应采用更大样本量并考虑临床因素与肠道微生物组在治疗过程中的复杂相互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The composition of the gut microbiome has been associated with clinical responses to immune checkpoint inhibitor (ICI) treatment, but there is limited consensus on the specific microbiome characteristics linked to the clinical benefits of ICIs. We performed shotgun metagenomic sequencing of stool samples collected before ICI initiation from five observational cohorts recruiting ICI-naive patients with advanced cutaneous melanoma (n = 165). Integrating the dataset with 147 metagenomic samples from previously published studies, we found that the gut microbiome has a relevant, but cohort-dependent, association with the response to ICIs. A machine learning analysis confirmed the link between the microbiome and overall response rates (ORRs) and progression-free survival (PFS) with ICIs but also revealed limited reproducibility of microbiome-based signatures across cohorts. Accordingly, a panel of species, including Bifidobacterium pseudocatenulatum, Roseburia spp. and Akkermansia muciniphila, associated with responders was identified, but no single species could be regarded as a fully consistent biomarker across studies. Overall, the role of the human gut microbiome in ICI response appears more complex than previously thought, extending beyond differing microbial species simply present or absent in responders and nonresponders. Future studies should adopt larger sample sizes and take into account the complex interplay of clinical factors with the gut microbiome over the treatment course.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Lee KA, Thomas AM, Bolte LA, et al. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nat Med. 2022. PMID: 35228751. doi:10.1038/s41591-022-01695-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。